CION Ameerpet
Childhood Cancer Types — Parent’s Guide
Ewing sarcoma in children — what every parent needs to know
Medically reviewed by Dr. C. Raghavendra Reddy, DM (Medical Oncology, Gold Medal) · Last reviewed June 2026
If your child has been diagnosed with Ewing sarcoma — also called childhood Ewing sarcoma or Ewing tumour — you deserve a clear and honest explanation of what this means. Ewing sarcoma is a rare cancer that develops in bone or the soft tissue around it. It most often affects children and teenagers. This page explains what Ewing sarcoma is, what signs to look for, how it is diagnosed, and what treatment involves, written for parents in plain language.
- Tumor board for every child — not one doctor’s opinion; a full multidisciplinary team reviews each case before any treatment begins
- 45-minute consultations — your questions are heard fully; no rushed decisions about your child’s treatment plan
- Free first consultation — paediatric oncology assessment at no charge for first-time patients
- Transparent costs — a written treatment plan and cost breakdown before anything begins
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Understanding the diagnosis
What is Ewing sarcoma in children?
Ewing sarcoma is a cancer that develops in bone or the soft tissue that surrounds it. It belongs to a group called the Ewing sarcoma family of tumours (ESFT). All tumours in this family share a specific genetic change — a translocation between chromosomes 11 and 22 — that causes a normal gene to produce an abnormal fusion protein. This protein drives the cells to divide uncontrollably. The cancer is named after James Ewing, who first described it in the 1920s.
Ewing sarcoma most commonly affects children and teenagers, typically between the ages of 10 and 20, though it can occur in younger children and occasionally in adults. It arises most often in the long bones of the limbs — particularly the thigh bone (femur), the bones of the lower leg (tibia and fibula), and the upper arm bone (humerus) — as well as in the flat bones of the pelvis, ribs, and spine. In roughly one in four to five cases, the tumour starts not in bone itself but in the surrounding soft tissue; this is called extraosseous Ewing sarcoma.
Childhood Ewing sarcoma is not caused by an inherited family trait in the vast majority of cases, nor by anything the child was exposed to, ate, or did. The genetic translocation at the heart of the disease arises by chance in a single cell. There is nothing a parent could have done to prevent it. Understanding this clearly is important, because many families carry an unnecessary burden of self-blame when a cancer diagnosis arrives.
One of the features that makes Ewing tumour particularly important to diagnose carefully is that it can spread early — most commonly to the lungs, other bones, and bone marrow. Staging at diagnosis therefore involves imaging of the whole body, not just the local tumour site. Understanding whether or not the disease has spread significantly affects treatment planning, which is why a complete, specialist-led diagnostic workup matters before treatment begins.
Sites and presentations
Where Ewing sarcoma appears and what it looks like
Ewing sarcoma does not always behave the same way. The site of the tumour and whether it has spread at the time of diagnosis are two of the most important factors in understanding the outlook and planning treatment. Here are the common presentations your child’s team may discuss.
Most common site
Long bones of the limbs
The most frequent site of childhood Ewing sarcoma is the shaft (diaphysis) or the end region (metaphysis or metadiaphysis) of long bones. The femur (thigh bone), tibia, and fibula (lower leg bones) are most often involved in the lower limbs; the humerus (upper arm) is the most common upper limb site. A child may present with pain that worsens at night, localised swelling, or tenderness directly over the bone.
- Pain is the earliest and most consistent symptom
- Swelling develops as the tumour grows through the bone cortex
- Limb-salvage surgery is possible for many limb Ewing tumours
Common — flat bones
Pelvis, ribs, and spine
The pelvis is the second most common primary site and is associated with a higher likelihood of large tumour size at presentation, because pelvic tumours often grow without visible swelling for longer. Rib and spinal involvement can cause chest pain, difficulty breathing, or back pain. Spinal Ewing tumours may cause nerve compression symptoms such as leg weakness or bladder changes if the tumour presses on the spinal cord or nerve roots.
- Pelvic tumours may be large at diagnosis due to late-presenting symptoms
- Rib involvement can cause chest pain or a chest wall mass
- Spinal tumours require urgent evaluation if neurological symptoms develop
Roughly 1 in 5 cases
Extraosseous (soft tissue) Ewing sarcoma
In approximately one in four to five cases, Ewing sarcoma arises in soft tissue rather than bone itself. This is called extraosseous Ewing sarcoma. It can occur in the chest wall, abdominal or pelvic soft tissue, limbs, or the head and neck region. The presenting sign is usually a soft-tissue mass, which may or may not be painful. The same genetic translocation is found as in bone Ewing sarcoma, and treatment is approached in the same overall framework.
- May present as a painless or mildly tender soft-tissue lump
- Same molecular diagnosis as bone Ewing sarcoma
- Chest-wall extraosseous Ewing tumours (Askin tumour) are a recognised variant
Spread at diagnosis
Metastatic Ewing sarcoma
In some children, Ewing sarcoma has spread to distant sites by the time of diagnosis. The lungs are the most common site of spread, followed by other bones and bone marrow. Less commonly, the liver may be involved. The presence of metastatic disease significantly changes the treatment plan and requires the full diagnostic staging workup — chest CT, bone scan or whole-body MRI, and bone marrow biopsy — so that the team has a complete picture before planning begins.
- Lungs are the most common distant site
- Bone and bone marrow metastases are the second most common pattern
- Full staging workup is essential before treatment begins
These are the broad categories. Your child’s precise presentation will be determined by imaging and biopsy results. The oncology team will explain what the findings mean for your child’s specific case. — Explore the pediatric cancer hub · Paediatric Cancer Treatment in Hyderabad
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your child deserves a team, not a single opinion
Our 17 oncologists review every paediatric case together at a tumour board — medical, surgical, and radiation specialists working as one. No rushed decisions.
Diagnosis and treatment
How childhood Ewing sarcoma is diagnosed and treated — step by step
A diagnosis of childhood ewing sarcoma sets off a sequence of steps, each of which builds the information the team needs before any treatment begins. Here is what that journey typically looks like.
Imaging of the affected area
The first investigation is usually a plain X-ray of the painful or swollen area. Ewing sarcoma has characteristic appearances on X-ray that a radiologist familiar with bone tumours will recognise — including a destructive lesion in the bone shaft, sometimes with a layered “onion-skin” pattern of new bone formation in the surrounding tissue. X-ray findings alone are not diagnostic, but they are sufficient to trigger urgent referral to a specialist centre. An MRI of the affected area then follows; this gives the oncology team a precise map of the tumour — its size, how far it extends within the bone, and whether it has pushed into the surrounding soft tissue. MRI is the gold standard for local assessment before surgery.
Staging — checking for spread
Because childhood Ewing sarcoma can spread to the lungs, other bones, and bone marrow, checking for distant spread is a critical part of the initial evaluation. This staging workup typically includes a CT scan of the chest (to look for lung metastases), a whole-body bone scan or whole-body MRI (to identify bone metastases), and a PET-CT scan in some centres, which can assess all of these in one examination. A bone marrow biopsy (usually bilateral, meaning from both sides of the pelvis) is done to determine whether cancer cells are present in the marrow. These results determine the stage and are essential before the treatment plan is finalised.
Biopsy and molecular confirmation
A biopsy — the removal of a small sample of tissue from the tumour — is the only way to confirm the diagnosis. This is a planned, precise procedure, usually done under sedation or general anaesthesia in children. It must be carried out by a surgeon who is experienced with bone tumour biopsies, because the biopsy track (the path the needle or instrument follows through tissue) must be planned so that it can be excised along with the tumour during the later surgery. A pathologist then examines the tissue under the microscope. Crucially, molecular testing is done on the biopsy sample to confirm the EWSR1 gene rearrangement — the characteristic genetic translocation of Ewing sarcoma. Without this confirmation, the treatment team cannot be certain of the diagnosis, and treatment must not begin.
Tumour board review and treatment planning
Once all imaging, staging, and biopsy results are in hand, the case is presented at a multidisciplinary tumour board — a meeting involving paediatric oncologists, surgical oncologists, radiation oncologists, radiologists, and pathologists. Together, they review every finding and agree on the best treatment plan for this specific child. This is not a formality. At CION, every paediatric oncology case is reviewed at the tumour board before a plan is presented to the family. When we sit with you to explain the plan in your 45-minute consultation, it represents the considered judgement of the whole team, not a single doctor’s opinion.
Induction chemotherapy (before surgery)
For most children with Ewing sarcoma, treatment begins with several cycles of chemotherapy given before surgery or radiation. This phase is called induction chemotherapy. The goals are to shrink the tumour to make local control (surgery or radiation) more effective, and to begin treating any microscopic cancer cells that may have spread beyond the visible tumour. Chemotherapy is given as an intravenous infusion, usually through a central line placed under the skin. The specific chemotherapy programme is chosen and supervised by the medical oncologist. Side effects vary by programme and are managed actively by the supportive care team. How well the tumour responds to induction chemotherapy is assessed by repeat imaging and influences subsequent decisions.
Local control — surgery, radiation, or both
After induction chemotherapy, the team proceeds to local control — treating the primary tumour site definitively. For tumours in the limbs, limb-salvage surgery is the goal for most children; the tumour is removed along with a margin of normal tissue, and the bone is reconstructed using a prosthesis or bone graft. Amputation is needed in a minority of cases where limb-salvage cannot be done safely. For tumours in locations where surgery is very difficult — such as the spine, sacrum, or some pelvic sites — radiation therapy precisely targeted at the tumour may be used as the primary local control modality, or in combination with surgery. The local control choice is decided jointly by the surgical oncologist and radiation oncologist after reviewing the response to chemotherapy.
Consolidation chemotherapy and ongoing monitoring
Following local control, further chemotherapy — called consolidation chemotherapy — is given to address any remaining microscopic disease and reduce the risk of relapse. The total duration of chemotherapy treatment (induction plus consolidation) spans several months. When chemotherapy is complete, the child enters a period of regular monitoring — clinical review, blood tests, and imaging at scheduled intervals. This monitoring continues for several years. The goal is to detect any signs of relapse early, when it can be addressed promptly, and to support the child’s recovery and return to normal life. The supportive care team — including nutritionists and psycho-oncology support — remains involved throughout.
Get a second opinion on your child’s diagnosis
Bring the biopsy result, reports, or scans. Our team will review them and explain what the findings mean and what the options are — clearly and without pressure.
Paediatric Oncology — CION Hyderabad
You walk this journey with us — not alone
Every decision about your child’s care is made for healing, not billing. Transparent costs. No unnecessary tests. A team behind every child.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Your questions about Ewing sarcoma in children — answered
What is Ewing sarcoma and why does it mainly affect children and teenagers?
Ewing sarcoma is a rare type of cancer that forms in bone or the soft tissue immediately surrounding bone. It belongs to a family of tumours called the Ewing sarcoma family of tumours (ESFT), all of which share a characteristic genetic change — a translocation, or swapping of genetic material, between chromosomes 11 and 22 in most cases. This translocation produces an abnormal protein that drives uncontrolled cell growth. The reason Ewing sarcoma predominantly affects children, teenagers, and young adults is not fully understood, but it is believed to be connected to periods of rapid skeletal growth. The cells involved in bone remodelling and growth are particularly active during these phases, and this may make them more vulnerable to the genetic events that trigger the tumour. It is not caused by injury, diet, or anything the child or family did. Most cases arise with no known risk factor.
What are the warning signs of Ewing sarcoma in a child?
The most common early sign of Ewing sarcoma is persistent pain in a bone — most often in the limbs (thigh, shin, upper arm) or the pelvis, spine, or ribs. The pain often worsens at night or during physical activity and does not go away with ordinary pain relief. A visible swelling, lump, or tenderness over the affected area is another frequent finding. Some children develop a low-grade fever, weight loss, or unexplained fatigue alongside the local symptoms. Because bone pain is common in growing children and is often attributed to growing pains or a sports knock, Ewing sarcoma can be overlooked for a period before the diagnosis is pursued. A parent who notices that bone pain is persistent, worsening, or accompanied by swelling should take the child to a doctor for imaging without delay. The sooner the diagnosis is made, the sooner a clear plan can be formed.
What tests are needed to diagnose Ewing sarcoma?
Diagnosing childhood Ewing sarcoma involves several steps and requires a specialist paediatric oncology team. Initial investigation starts with plain X-rays of the painful area, which can show characteristic changes to the bone. If X-ray findings are concerning, an MRI of the affected area is done to define the tumour precisely — its size, extent within the bone, and any involvement of surrounding soft tissue. A CT scan of the chest and a bone scan (or whole-body MRI or PET-CT) are used to look for spread to the lungs or other bones. A bone marrow biopsy checks for involvement of the marrow. The definitive diagnostic step is a biopsy of the tumour — a small sample of tissue is taken and examined under the microscope by a pathologist, who also carries out molecular tests to confirm the characteristic genetic translocation. This genetic confirmation is important because it distinguishes Ewing sarcoma from other bone tumours that can look similar. Blood tests including a full blood count and inflammatory markers are also done. All results together allow the team to confirm the diagnosis, determine the stage, and plan treatment.
Does Ewing sarcoma always start in bone?
No. Although bone is the most common site, roughly one in four to five cases of Ewing sarcoma starts in soft tissue — the muscles, connective tissue, or fat — rather than directly in a bone. This form is sometimes called extraosseous Ewing sarcoma or soft-tissue Ewing sarcoma. The same genetic translocation is found in both bone and soft-tissue forms. Soft-tissue Ewing sarcoma can occur in the chest wall, abdomen, pelvis, limbs, or head and neck region. Whether a child's tumour is in bone or soft tissue, the diagnosis is confirmed by the same genetic and pathological tests, and the overall approach to treatment is similar. The location of the tumour and whether it has spread are what most directly influence the treatment plan.
What does treatment for Ewing sarcoma in children involve?
Treatment for childhood Ewing sarcoma is multi-modal — meaning it combines several types of treatment, not just one. The standard approach for most children involves an initial phase of chemotherapy, given before surgery, to shrink the tumour and treat any cells that may have spread beyond the visible tumour site. After the chemotherapy response is assessed, local control is planned — this means either surgery to remove the tumour, radiation therapy directed precisely at the tumour site, or a combination of both. Following local control, further chemotherapy is given to address any remaining microscopic disease. The specific chemotherapy programme, the choice between surgery and radiation for local control, and the overall duration of treatment are all decided by a multidisciplinary tumour board including paediatric oncologists, surgical oncologists, and radiation oncologists. At CION, every child’s case is reviewed by our full team before any treatment begins. We do not make rushed decisions. Your child’s 45-minute consultation will give you the time you need to understand the plan fully.
If Ewing sarcoma is in the leg bone, will my child lose the limb?
Not necessarily. Advances in surgical techniques and the effective use of chemotherapy to shrink the tumour before surgery mean that limb-salvage surgery — removing the tumour while preserving the limb — is possible for many children with Ewing sarcoma in a limb bone. The feasibility of limb-salvage depends on the size and location of the tumour, how much it has responded to pre-operative chemotherapy, and whether the tumour is close to critical nerves or blood vessels. In situations where limb-salvage is not safe or would leave the child with a limb that does not function well, amputation may give a better functional outcome. Radiation therapy to the bone is an alternative for local control when surgery is not feasible. These decisions are always made by a multidisciplinary team after careful review of imaging and in discussion with the family. Many children with Ewing sarcoma treated at specialist centres go on to live fully active lives.
Pediatric Cancer A–Z
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.